US equities |
NVDA $239.69 ▲+2.45% SPCX $169.63 ▲+6.71% MU $1,061.17 ▼-1.28% TSLA $380.74 ▲+2.74% SNDK $1,694.82 ▼-1.46% MSFT $528.72 ▲+2.16% INTC $116.47 ▼-2.39% META $743.54 ▲+2.12%
FinancialContent

Articles published by Beacon Biosignals

News headline image
Beacon Biosignals Unifies Brands, Bringing CleveMed and SleepView® Under the Beacon Name
From Beacon Biosignals
Via GlobeNewswire
News headline image
Beacon Biosignals Upsizes Series B Financing to Over $97 Million
From Beacon Biosignals
Via GlobeNewswire
News headline image
Beacon Biosignals Announces Partnership with Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative EEG
From Beacon Biosignals
Via GlobeNewswire
Tickers HRMY
News headline image
Beacon Biosignals Announces Multi-Year Expansion of Strategic Collaboration with Takeda to Advance Narcolepsy Diagnosis and Neurobiomarker Discovery
From Beacon Biosignals
Via GlobeNewswire
News headline image
Beacon Biosignals Raises $86M to Accelerate AI-Driven Insights into Brain Health
From Beacon Biosignals
Via GlobeNewswire
News headline image
Beacon Biosignals Reports Novel Sleep EEG Results from Multiple Industry Collaborations at the American Epilepsy Society Annual Meeting
From Beacon Biosignals
Via GlobeNewswire
News headline image
FDA Authorizes Beacon’s Dreem 3S as First Sleep Wearable with Predetermined Change Control Plan, Paving the Way for Continuous Algorithm Enhancements in Sleep Monitoring
From Beacon Biosignals
Via GlobeNewswire
News headline image
Beacon Biosignals Announces Strategic Collaboration with Skye Bioscience to Integrate Sleep Quality and Sleep Apnea Endpoints in CBEYOND™ Phase 2 Trial of Nimacimab for Obesity
From Beacon Biosignals
Via GlobeNewswire
Tickers SKYE
News headline image
Beacon Biosignals Selected by Longboard Pharmaceuticals to Advance Understanding of Epilepsy and Related Conditions
From Beacon Biosignals
Via GlobeNewswire
News headline image
Beacon Biosignals and Takeda Launch Strategic Collaboration to Advance Neurobiomarkers and Endpoints for Sleep Disorders
From Beacon Biosignals
Via GlobeNewswire